Drug General Information
Drug ID
D0SD8Q
Former ID
DNC000329
Drug Name
BMS-193885
Drug Type
Small molecular drug
Indication Discovery agent Investigative [535359]
Structure
Download
2D MOL

3D MOL

Formula
C33H42N4O6
Canonical SMILES
CC1=C(C(C(=C(N1)C)C(=O)OC)C2=CC(=CC=C2)NC(=O)NCCCN3CCC(<br />CC3)C4=CC(=CC=C4)OC)C(=O)OC
InChI
1S/C33H42N4O6/c1-21-28(31(38)42-4)30(29(22(2)35-21)32(39)43-5)25-10-6-11-26(19-25)36-33(40)34-15-8-16-37-17-13-23(14-18-37)24-9-7-12-27(20-24)41-3/h6-7,9-12,19-20,23,30,35H,8,13-18H2,1-5H3,(H2,34,36,40)
InChIKey
WMYSXJSJXZFODY-UHFFFAOYSA-N
CAS Number
CAS 54739-18-3
PubChem Compound ID
PubChem Substance ID
ChEBI ID
ChEBI:5138
SuperDrug ATC ID
N06AB08
SuperDrug CAS ID
cas=054739183
Target and Pathway
Target(s) Neuropeptide Y receptor type 1 Target Info Antagonist [535359]
KEGG Pathway cAMP signaling pathway
Neuroactive ligand-receptor interaction
NetPath Pathway FSH Signaling Pathway
Reactome Peptide ligand-binding receptors
G alpha (i) signalling events
WikiPathways GPCRs, Class A Rhodopsin-like
Peptide GPCRs
Endothelin Pathways
GPCR ligand binding
GPCR downstream signaling
References
Ref 535359Dihydropyridine neuropeptide Y Y(1) receptor antagonists. Bioorg Med Chem Lett. 2002 Feb 11;12(3):379-82.
Ref 535359Dihydropyridine neuropeptide Y Y(1) receptor antagonists. Bioorg Med Chem Lett. 2002 Feb 11;12(3):379-82.

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.